TGF-β signaling regulates differentiation of MSCs in bone metabolism: disputes among viewpoints

Stem Cell Res Ther. 2024 May 31;15(1):156. doi: 10.1186/s13287-024-03761-w.

Abstract

Mesenchymal stem cells (MSCs) are multipotent cells that can differentiate into cells of different lineages to form mesenchymal tissues, which are promising in regard to treatment for bone diseases. Their osteogenic differentiation is under the tight regulation of intrinsic and extrinsic factors. Transforming growth factor β (TGF-β) is an essential growth factor in bone metabolism, which regulates the differentiation of MSCs. However, published studies differ in their views on whether TGF-β signaling regulates the osteogenic differentiation of MSCs positively or negatively. The controversial results have not been summarized systematically and the related explanations are required. Therefore, we reviewed the basics of TGF-β signaling and summarized how each of three isoforms regulates osteogenic differentiation. Three isoforms of TGF-β (TGF-β1/β2/β3) play distinct roles in regulating osteogenic differentiation of MSCs. Additionally, other possible sources of conflicts are summarized here. Further understanding of TGF-β signaling regulation in MSCs may lead to new applications to promote bone regeneration and improve therapies for bone diseases.

Keywords: Bone metabolism; MSCs; Osteogenic differentiation; TGF-β.

Publication types

  • Review

MeSH terms

  • Animals
  • Bone and Bones* / cytology
  • Bone and Bones* / metabolism
  • Cell Differentiation*
  • Humans
  • Mesenchymal Stem Cells* / cytology
  • Mesenchymal Stem Cells* / metabolism
  • Osteogenesis*
  • Signal Transduction*
  • Transforming Growth Factor beta* / metabolism

Substances

  • Transforming Growth Factor beta